78 related articles for article (PubMed ID: 21475829)
1. Inhibitory effects of chemically modified heparin on the P-selectin-mediated adhesion of breast cancer cells in vitro.
Mi D; Gao Y; Zheng S; Ba X; Zeng X
Mol Med Rep; 2009; 2(2):301-6. PubMed ID: 21475829
[TBL] [Abstract][Full Text] [Related]
2. Chemically modified heparin inhibits the in vitro adhesion of nonsmall cell lung cancer cells to P-selectin.
Gao Y; Wei M; Zheng S; Ba X; Hao S; Zeng X
J Cancer Res Clin Oncol; 2006 Apr; 132(4):257-64. PubMed ID: 16331491
[TBL] [Abstract][Full Text] [Related]
3. Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions.
Wei M; Tai G; Gao Y; Li N; Huang B; Zhou Y; Hao S; Zeng X
J Biol Chem; 2004 Jul; 279(28):29202-10. PubMed ID: 15133030
[TBL] [Abstract][Full Text] [Related]
4. Chemically modified heparin inhibits in vitro L-selectin-mediated human ovarian carcinoma cell adhesion.
Chen Z; Jing Y; Song B; Han Y; Chu Y
Int J Gynecol Cancer; 2009 May; 19(4):540-6. PubMed ID: 19509548
[TBL] [Abstract][Full Text] [Related]
5. P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.
Hostettler N; Naggi A; Torri G; Ishai-Michaeli R; Casu B; Vlodavsky I; Borsig L
FASEB J; 2007 Nov; 21(13):3562-72. PubMed ID: 17557930
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of heparin and glucan sulfates binding to P-selectin and its impact on the general understanding of selectin inhibition.
Simonis D; Fritzsche J; Alban S; Bendas G
Biochemistry; 2007 May; 46(20):6156-64. PubMed ID: 17458940
[TBL] [Abstract][Full Text] [Related]
7. Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis.
Borsig L
Semin Thromb Hemost; 2007 Jul; 33(5):540-6. PubMed ID: 17629852
[TBL] [Abstract][Full Text] [Related]
8. Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches.
Fritzsche J; Simonis D; Bendas G
Thromb Haemost; 2008 Dec; 100(6):1166-75. PubMed ID: 19132244
[TBL] [Abstract][Full Text] [Related]
9. Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysis.
Maddineni J; Jeske WP; Baltasar F; Cornelli U; Manoni M; Hoppensteadt DA; Fareed J
Clin Appl Thromb Hemost; 2006 Jul; 12(3):311-7. PubMed ID: 16959684
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of heparin induced anti-cancer activity in experimental cancer models.
Niers TM; Klerk CP; DiNisio M; Van Noorden CJ; Büller HR; Reitsma PH; Richel DJ
Crit Rev Oncol Hematol; 2007 Mar; 61(3):195-207. PubMed ID: 17074500
[TBL] [Abstract][Full Text] [Related]
11. Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects.
Stevenson JL; Varki A; Borsig L
Thromb Res; 2007; 120 Suppl 2():S107-11. PubMed ID: 18023703
[TBL] [Abstract][Full Text] [Related]
12. The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity.
Fritzsche J; Alban S; Ludwig RJ; Rubant S; Boehncke WH; Schumacher G; Bendas G
Biochem Pharmacol; 2006 Aug; 72(4):474-85. PubMed ID: 16780802
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell invasion of three-dimensional matrices of defined composition: evidence for a specific role for heparan sulfate in rodent cell lines.
Robertson NP; Starkey JR; Hamner S; Meadows GG
Cancer Res; 1989 Apr; 49(7):1816-23. PubMed ID: 2522348
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins.
Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U
J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988
[TBL] [Abstract][Full Text] [Related]
15. P-Selectin-mediated acute inflammation can be blocked by chemically modified heparin, RO-heparin.
Gao Y; Li N; Fei R; Chen Z; Zheng S; Zeng X
Mol Cells; 2005 Jun; 19(3):350-5. PubMed ID: 15995351
[TBL] [Abstract][Full Text] [Related]
16. Gangliosides expressed on breast cancer cells are E-selectin ligands.
Shirure VS; Henson KA; Schnaar RL; Nimrichter L; Burdick MM
Biochem Biophys Res Commun; 2011 Mar; 406(3):423-9. PubMed ID: 21329670
[TBL] [Abstract][Full Text] [Related]
17. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin.
Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M
Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816
[TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate and chondroitin sulfate proteoglycans inhibit E-selectin binding to endothelial cells.
Luo J; Kato M; Wang H; Bernfield M; Bischoff J
J Cell Biochem; 2001; 80(4):522-31. PubMed ID: 11169736
[TBL] [Abstract][Full Text] [Related]
19. Heparin-like glycosaminoglycans participate in binding of a human trophoblastic cell line (JAR) to a human uterine epithelial cell line (RL95).
Rohde LH; Carson DD
J Cell Physiol; 1993 Apr; 155(1):185-96. PubMed ID: 8468365
[TBL] [Abstract][Full Text] [Related]
20. Study on anti-metastasis of heparin derivatives as ligand antagonist of p-selectin.
Li Y; Luo JY; Cui HF; Zheng L; Du SS
Biomed Pharmacother; 2010 Dec; 64(10):654-8. PubMed ID: 20970300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
